An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma (NPC): Preliminary report
机构：[1]Cancer Center, Sun Yat-sen University, Guangzhou, China[2]Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China[3]Sichuan Cancer Hospital, Chengdu, China四川省肿瘤医院[4]Fujian Cancer Hospital, Fuzhou, China[5]Fudan University Cancer Center, Shanghai, China[6]Guizhou Cancer Hospital, Guiyang, China[7]The First Affiliated Hospital of Guangxi Medical University, Nanning, China[8]Hubei Cancer Clinical Study Center and Zhongnan Hospital of Wuhan University, Wuhan, China
第一作者机构：[1]Cancer Center, Sun Yat-sen University, Guangzhou, China[2]Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China[3]Sichuan Cancer Hospital, Chengdu, China[4]Fujian Cancer Hospital, Fuzhou, China[5]Fudan University Cancer Center, Shanghai, China[6]Guizhou Cancer Hospital, Guiyang, China[7]The First Affiliated Hospital of Guangxi Medical University, Nanning, China[8]Hubei Cancer Clinical Study Center and Zhongnan Hospital of Wuhan University, Wuhan, China
推荐引用方式(GB/T 7714)：
Lu T.,Zhao C.,Chen C.,et al.An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma (NPC): Preliminary report[J].JOURNAL OF CLINICAL ONCOLOGY.2010,28(15):
APA：
Lu, T.,Zhao, C.,Chen, C.,Gao, L.,Lang, J....&Xie, C..(2010).An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma (NPC): Preliminary report.JOURNAL OF CLINICAL ONCOLOGY,28,(15)
MLA：
Lu, T.,et al."An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma (NPC): Preliminary report".JOURNAL OF CLINICAL ONCOLOGY 28..15(2010)
医学